Literature DB >> 24824758

Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertensive patients.

Chang-yi Wang1, Zhong-wei Chen2, Tao Zhang2, Jun Liu3, Si-han Chen2, Sheng-yuan Liu2, Li-yuan Han4, Zhao-hui Hui5, Yu-ming Chen6.   

Abstract

BACKGROUND: Accumulating data suggest that hyperhomocysteinemia is associated with the risk of ischemic stroke (IS) and coronary heart disease (CHD) in the general population, but the relationship remains unclear in hypertensive patients. We examined the association of total homocysteine (tHcy) with IS and CHD in hypertensive patients.
METHODS: A total of 5935 Chinese hypertensive patients were recruited in a community-based cross-sectional study from 60 communities in Shenzhen, China. Plasma tHcy was quantitatively measured using the enzyme cycle method. Conventional risk factors for IS and CHD were obtained through questionnaire interviews and physical examinations. We included cerebral infarction, embolism and small-vessel disease as IS; and myocardial infarction, angina pectoris, coronary revascularization, and cardiac arrest as CHD. IS and CHD were retrospectively adjudicated by specialists via interviews, hospital records or relevant tests.
RESULTS: Significantly higher values of tHcy were observed in IS patients than in non-IS controls among both men and women. Greater tHcy level was dose dependently associated with an increased risk of IS presence in women, men and them combined (p-trend: 0.002, 3.8×10(-4) and 0.001). The odds ratios (95% CI) of IS for tHcy ≥30 (vs. <15) μmol/L were 2.84 (1.73-4.34) in men, 4.41 (1.62-9.15) in women, and 2.86 (1.72-4.75) in their combination after adjusting for other main risk factors of IS. We did not find any significant association between tHcy and presence of CHD after the adjustment for covariates.
CONCLUSIONS: Plasma homocysteine level is positively associated with the presence of IS, but not CHD, in Chinese hypertensive patients.
Copyright © 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coronary heart disease; Homocysteine; Hypertension; Ischemic stroke

Mesh:

Year:  2014        PMID: 24824758     DOI: 10.1016/j.ejim.2014.04.011

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  20 in total

1.  Plasma Homocysteine and Prognosis of Acute Ischemic Stroke: a Gender-Specific Analysis From CATIS Randomized Clinical Trial.

Authors:  Chongke Zhong; Tan Xu; Tian Xu; Yanbo Peng; Aili Wang; Jinchao Wang; Hao Peng; Qunwei Li; Deqin Geng; Dongsheng Zhang; Yuming Zhang; Yonghong Zhang; Xiang Gao; Jiang He
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

2.  Association of long noncoding RNA H19 polymorphisms with the susceptibility and clinical features of ischemic stroke in southern Chinese Han population.

Authors:  Jiao Huang; Jialei Yang; Jinhong Li; Zhaoxia Chen; Xiaojing Guo; Siyun Huang; Lian Gu; Li Su
Journal:  Metab Brain Dis       Date:  2019-04-30       Impact factor: 3.584

3.  Adaptive regulation of riboflavin transport in heart: effect of dietary riboflavin deficiency in cardiovascular pathogenesis.

Authors:  Tamilarasan Udhayabanu; Sellamuthu Karthi; Ayyavu Mahesh; Perumal Varalakshmi; Andreea Manole; Henry Houlden; Balasubramaniem Ashokkumar
Journal:  Mol Cell Biochem       Date:  2017-08-23       Impact factor: 3.396

4.  Status of hyperhomocysteinemia in China: results from the China Stroke High-risk Population Screening Program, 2018.

Authors:  Wenjun Tu; Feng Yan; Baohua Chao; Xunming Ji; Longde Wang
Journal:  Front Med       Date:  2021-12-10       Impact factor: 4.592

5.  Dose-response association between plasma homocysteine and white matter lesions in patients with hypertension: a case-control study.

Authors:  Yujuan Yuan; Xintian Cai; Yan Liu; Nanfang Li
Journal:  Hypertens Res       Date:  2022-08-23       Impact factor: 5.528

6.  Association between Elevated Plasma Homocysteine and Low Skeletal Muscle Mass in Asymptomatic Adults.

Authors:  Jae-Hyeong Choi; Jin-Woo Seo; Mi-Yeon Lee; Yong-Taek Lee; Kyung Jae Yoon; Chul-Hyun Park
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-08

7.  Gender differences in the risk factors for endothelial dysfunction in Chinese hypertensive patients: homocysteine is an independent risk factor in females.

Authors:  Cheng Cao; Jianxin Hu; Yifei Dong; Rui Zhan; Ping Li; Hai Su; Qiang Peng; Tao Wu; Liang Lei; Xiao Huang; Qinghua Wu; Xiaoshu Cheng
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

8.  Ethnic differences in the prevalence of high homocysteine levels among low-income rural Kazakh and Uyghur adults in far western China and its implications for preventive public health.

Authors:  Shuxia Guo; Hongrui Pang; Heng Guo; Mei Zhang; Jia He; Yizhong Yan; Qiang Niu; Dongsheng Rui; Shugang Li; Rulin Ma; Jingyu Zhang; Jiaming Liu; Yusong Ding
Journal:  Int J Environ Res Public Health       Date:  2015-05-19       Impact factor: 3.390

9.  Effect of folic acid combined with pravastatin on arteriosclerosis in elderly hypertensive patients with lacunar infarction.

Authors:  Chunxia Li; Xingpeng Bu; Yaru Liu
Journal:  Medicine (Baltimore)       Date:  2021-07-16       Impact factor: 1.817

10.  Serum Homocysteine Concentration Is Significantly Associated with Inflammatory/Immune Factors.

Authors:  Tianyu Li; Yang Chen; Jie Li; Xiaobo Yang; Haiying Zhang; Xue Qin; Yanling Hu; Zengnan Mo
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.